Bristol-Myers, Pfizer Report Stroke, Systemic Embolism, Major Bleeding Uncommon in Eliquis Phase 3 ARISTOTLE Trial
August 31, 2013 at 11:46 AM EDT
- Bristol-Myers Squibb Company (NYSE: BMY ) and Pfizer Inc. (NYSE: PFE ) today announced results of a post-hoc subanalysis from the Phase III ARISTOTLE trial. Patients with
